What you Missed:
Ready to Catalyze the Next Wave of Inflammasome Therapies?
The 7th Inflammasome Therapeutics Summit is your go-to forum for drug developers, translational scientists, and immunology innovators striving to push inflammasome-targeted therapies from concept to clinic. Join 70+ leaders across pharma, biotech, and academia as they converge to decode the latest clinical readouts and explore novel therapeutic avenues beyond NLRP3.
Over three action-packed days, we will unpack high-impact case studies from the front lines – covering emerging upstream and downstream targets, mechanisms beyond canonical pathways, and how these insights are unlocking new disease areas from neuroinflammation and atopic dermatitis to obesity and fibrotic conditions.
Get ready for in-depth sessions on optimizing translational models, identifying next-gen biomarkers, and mapping inflammasome signaling across diverse indications. If you are serious about leading the charge in inflammasome drug development, this is where the future takes shape.
Data-Driven Case Studies You Missed:
Uncovering the latest breakthroughs in inflammasome biology, from novel activation pathways to structural mechanisms and therapeutic implications with Pfizer, EMUNO Therapeutics, TheraVac Biologics, and Azome Therapeutic
Addressing translational challenges from preclinical models to human trials including biomarker development and patient stratification with Inflammasome Therapeutics and Neumora
Evaluating disease-specific opportunities across neuroinflammation, autoimmune and metabolic disorders, and beyond with Ventyx Biosciences, AC Immune, and ZyVersa Therapeutics
Facilitating cross-disciplinary collaborations between pharma, biotech, and academia to accelerate clinical impact and commercialization
Explore the Agenda
Discover the key discussions from the summit, covering breakthroughs in inflammasome biology, emerging therapeutic targets, and the latest clinical and translational insights.
Partner With Us
Showcase your expertise alongside organizations advancing inflammasome-targeted drug development, from biomarker discovery to translational and clinical research.
Join Biopharma Experts
Connect with leading drug developers, immunology researchers, and biotech innovators working to advance the next generation of inflammasome therapeutics.